Production (Stage)
Oruka Therapeutics, Inc.
ORKA
$12.58
$0.393.20%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -105.26M | -91.34M | -- | -- | -- |
| Total Depreciation and Amortization | 45.50K | 29.50K | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 18.63M | 15.57M | -- | -- | -- |
| Change in Net Operating Assets | 2.79M | 12.64M | -- | -- | -- |
| Cash from Operations | -83.80M | -63.09M | -- | -- | -- |
| Capital Expenditure | -219.20K | -206.20K | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -317.05M | -359.93M | -- | -- | -- |
| Cash from Investing | -317.27M | -360.14M | -- | -- | -- |
| Total Debt Issued | 2.27M | 27.25M | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 454.57M | 454.57M | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 266.50K | 3.20M | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 5.39M | 5.39M | -- | -- | -- |
| Cash from Financing | 462.50M | 490.41M | -- | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 61.43M | 67.17M | -- | -- | -- |